Login to Your Account

Yahoo! Fresenius' Pilot-Study News Good, Not Bad, for Affy

By Randy Osborne
Staff Writer

Friday, February 15, 2013
Affymax Inc.'s morning Wall Street sell-off reversed itself by the afternoon on Thursday, as shareholders began to understand what the decision by dialysis firm Fresenius Medical Care North America – in contract negotiations with Affymax – really meant.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription